Steven Kanner

Steven Kanner

Company: Caribou Biosciences

Job title: Chief Scientific Officer


Roundtable Discussion: Exploring Safety, Function and Potency of Allogeneic CAR-T Cells 4:30 pm

Read more

day: Day 1 – Track B – Evening

Next Generation Allogeneic CAR-T Cell Therapies for Hematologic Malignancies 2:30 pm

• Next-generation genome editing platform to develop allogeneic CAR-T cell therapies • Implementation of armouring strategies to promote CAR-T cell persistenceRead more

day: Day 1 – Track B – Afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.